Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Malaria is a leading cause of death and illness around the world. Over 200 million cases are reported every year, and more than 400 000 people die. More than 90% of cases are reported in sub-Saharan Africa. Scientists have spent decades searching for an effective vaccine. Hence the recent excitement when Malawi’s government announced it had launched a pilot programme for the world’s first malaria vaccine, RTS,S (also known as Mosquirix©), produced by the pharmaceutical company, GSK. It’s the first vaccine to demonstrate significant reduction in malaria in children. The Conversation Africa’s Ina Skosana asked immunologist Faith Osier about RTS,S.

The Conversation logo

Engaging youth in health and research in rural Cambodia: a qualitative study.

Journal article

Ean M. et al, (2026), Global health action, 19

The coronaviral landscape across diverse mammalian species in the Northeastern United States

Journal article

Ibemgbo S. et al, (2026), Scientific Reports, 16

Seasonal dynamics and control of malaria: A non-autonomous model incorporating vaccination and drug resistance

Journal article

Onah IS., (2026), Nonlinear Analysis: Real World Applications, 91, 104584 - 104584

Trends and correlations in antimicrobial resistance indicators in 110 hospitals in Thailand, 2022-2024

Journal article

Werayingyong P. et al, (2026), International Journal of Infectious Diseases, 170, 108830 - 108830

A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment

Journal article

Donovan J. et al, (2026), Journal of Infection, 93, 106796 - 106796

Community acquired bacteremia in older adults: International and prospective infectious diseases-international research initiative (ID-IRI) study

Journal article

Sokulmez-Yildirim S. et al, (2026), International Journal of Infectious Diseases, 169

A Clinically-Oriented Antimicrobial Resistance Surveillance Network 2 (ACORN2): Results from three hospitals in Vietnam

Journal article

Thi HN. et al, (2026), International Journal of Infectious Diseases, 168, 108673 - 108673

Determinants of fatalities and secondary transmission in laboratory pathogen incidents, 1900–2025

Journal article

Dhawan S. et al, (2026), Journal of Infection, 93, 106766 - 106766

Faecal colonization with extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella pneumoniae in rural Burkina Faso

Journal article

Valia D. et al, (2026), Clinical Microbiology and Infection, 32, 1125 - 1134

Effect of higher dose primaquine for the radical cure of Plasmodium vivax malaria in Indonesia: a systematic review and individual patient data meta-analysis

Journal article

Fadilah I. et al, (2026), The Lancet Regional Health - Western Pacific, 72, 101908 - 101908

Population Pharmacokinetics and Pharmacodynamics of Paracetamol in Malaysian Patients With Plasmodium knowlesi Malaria.

Journal article

Wattanakul T. et al, (2026), CPT: pharmacometrics & systems pharmacology, 15

Load More